Global, regional and national burden of pancreatic cancer and its attributable risk factors from 2019 to 2021, with projection to 2044
BackgroundTo estimate the global burden of pancreatic cancer in 2019 and 2021 including incidence, mortality, and disability-adjusted-life-years (DALYs).MethodsData on pancreatic cancer incidence, mortality and DALYs were downloaded from the Global Health Data Exchange. The 95% uncertainty intervals...
Saved in:
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-01-01
|
| Series: | Frontiers in Oncology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2024.1521788/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1841540098231894016 |
|---|---|
| author | Xiao Li Yi Zhang Zeyi Yan Wenkai Jiang Shaozhen Rui Shaozhen Rui |
| author_facet | Xiao Li Yi Zhang Zeyi Yan Wenkai Jiang Shaozhen Rui Shaozhen Rui |
| author_sort | Xiao Li |
| collection | DOAJ |
| description | BackgroundTo estimate the global burden of pancreatic cancer in 2019 and 2021 including incidence, mortality, and disability-adjusted-life-years (DALYs).MethodsData on pancreatic cancer incidence, mortality and DALYs were downloaded from the Global Health Data Exchange. The 95% uncertainty intervals (UIs) were reported for annual numbers and rates (per 100,000 populations).ResultsIn 2021, there were 508,532 (95% UI: 462,09 to 547,208) incident cases of pancreatic cancer globally, of which 273,617 (250,808 to 299,347; 53.8%) were in males. The age-standardized incidence rate was 6.0 (5.5 to 6.5) per 100,000 people in 2019 and decreased to 5.9 (5.4 to 6.4) per 100,000 people in 2021. There was a 3.9% increase in the number of deaths from pancreatic cancer from 486,869 (446,272 to 517,185) in 2019 to 505,752 (461,224 to 543,899) in 2021. There was a 3.5% increase in DALYs due to pancreatic cancer, increasing from 10.9 million (10.1 to 11.7) in 2019 to 11.3 million (10.5 to 12.2) in 2021. In 2021, the highest age-standardized death rates were observed in Greenland and Monaco, and the highest age-standardized DALY rates were observed in Greenland and Uruguay. The numbers of incident cases and deaths peaked at the ages of 70 to 74 years. The pancreatic cancer burden increased as the socio-demographic index increased. To 2044, the number of incident cases and deaths will be more than 875 thousand and 879 thousand, respectively.ConclusionThe disease burden of pancreatic cancer remains high, especially in high-income regions. More cancer prevention measures are needed in the future to reduce the burden of pancreatic cancer. |
| format | Article |
| id | doaj-art-2f4be801112144db95c9a5c3c3104ff9 |
| institution | Kabale University |
| issn | 2234-943X |
| language | English |
| publishDate | 2025-01-01 |
| publisher | Frontiers Media S.A. |
| record_format | Article |
| series | Frontiers in Oncology |
| spelling | doaj-art-2f4be801112144db95c9a5c3c3104ff92025-01-14T05:10:34ZengFrontiers Media S.A.Frontiers in Oncology2234-943X2025-01-011410.3389/fonc.2024.15217881521788Global, regional and national burden of pancreatic cancer and its attributable risk factors from 2019 to 2021, with projection to 2044Xiao Li0Yi Zhang1Zeyi Yan2Wenkai Jiang3Shaozhen Rui4Shaozhen Rui5The Second Clinical Medical School, Lanzhou University, Lanzhou, ChinaThe First School of Clinical Medicine, Lanzhou University, Lanzhou, ChinaThe First School of Clinical Medicine, Lanzhou University, Lanzhou, ChinaThe Second Clinical Medical School, Lanzhou University, Lanzhou, ChinaThe Second Clinical Medical School, Lanzhou University, Lanzhou, ChinaDepartment of General Surgery, The First Hospital of Lanzhou University, Lanzhou, ChinaBackgroundTo estimate the global burden of pancreatic cancer in 2019 and 2021 including incidence, mortality, and disability-adjusted-life-years (DALYs).MethodsData on pancreatic cancer incidence, mortality and DALYs were downloaded from the Global Health Data Exchange. The 95% uncertainty intervals (UIs) were reported for annual numbers and rates (per 100,000 populations).ResultsIn 2021, there were 508,532 (95% UI: 462,09 to 547,208) incident cases of pancreatic cancer globally, of which 273,617 (250,808 to 299,347; 53.8%) were in males. The age-standardized incidence rate was 6.0 (5.5 to 6.5) per 100,000 people in 2019 and decreased to 5.9 (5.4 to 6.4) per 100,000 people in 2021. There was a 3.9% increase in the number of deaths from pancreatic cancer from 486,869 (446,272 to 517,185) in 2019 to 505,752 (461,224 to 543,899) in 2021. There was a 3.5% increase in DALYs due to pancreatic cancer, increasing from 10.9 million (10.1 to 11.7) in 2019 to 11.3 million (10.5 to 12.2) in 2021. In 2021, the highest age-standardized death rates were observed in Greenland and Monaco, and the highest age-standardized DALY rates were observed in Greenland and Uruguay. The numbers of incident cases and deaths peaked at the ages of 70 to 74 years. The pancreatic cancer burden increased as the socio-demographic index increased. To 2044, the number of incident cases and deaths will be more than 875 thousand and 879 thousand, respectively.ConclusionThe disease burden of pancreatic cancer remains high, especially in high-income regions. More cancer prevention measures are needed in the future to reduce the burden of pancreatic cancer.https://www.frontiersin.org/articles/10.3389/fonc.2024.1521788/fullpancreatic cancerrisksincidencedeathdisability-adjusted life years |
| spellingShingle | Xiao Li Yi Zhang Zeyi Yan Wenkai Jiang Shaozhen Rui Shaozhen Rui Global, regional and national burden of pancreatic cancer and its attributable risk factors from 2019 to 2021, with projection to 2044 Frontiers in Oncology pancreatic cancer risks incidence death disability-adjusted life years |
| title | Global, regional and national burden of pancreatic cancer and its attributable risk factors from 2019 to 2021, with projection to 2044 |
| title_full | Global, regional and national burden of pancreatic cancer and its attributable risk factors from 2019 to 2021, with projection to 2044 |
| title_fullStr | Global, regional and national burden of pancreatic cancer and its attributable risk factors from 2019 to 2021, with projection to 2044 |
| title_full_unstemmed | Global, regional and national burden of pancreatic cancer and its attributable risk factors from 2019 to 2021, with projection to 2044 |
| title_short | Global, regional and national burden of pancreatic cancer and its attributable risk factors from 2019 to 2021, with projection to 2044 |
| title_sort | global regional and national burden of pancreatic cancer and its attributable risk factors from 2019 to 2021 with projection to 2044 |
| topic | pancreatic cancer risks incidence death disability-adjusted life years |
| url | https://www.frontiersin.org/articles/10.3389/fonc.2024.1521788/full |
| work_keys_str_mv | AT xiaoli globalregionalandnationalburdenofpancreaticcanceranditsattributableriskfactorsfrom2019to2021withprojectionto2044 AT yizhang globalregionalandnationalburdenofpancreaticcanceranditsattributableriskfactorsfrom2019to2021withprojectionto2044 AT zeyiyan globalregionalandnationalburdenofpancreaticcanceranditsattributableriskfactorsfrom2019to2021withprojectionto2044 AT wenkaijiang globalregionalandnationalburdenofpancreaticcanceranditsattributableriskfactorsfrom2019to2021withprojectionto2044 AT shaozhenrui globalregionalandnationalburdenofpancreaticcanceranditsattributableriskfactorsfrom2019to2021withprojectionto2044 AT shaozhenrui globalregionalandnationalburdenofpancreaticcanceranditsattributableriskfactorsfrom2019to2021withprojectionto2044 |